Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY6 | Q15077 | 3/20 | 0.58 |
| ▸ | TAS2R38 | P59533 | 1/20 | 0.50 |
| ▸ | MIF | P14174 | 1/20 | 0.43 |
| ▸ | RAD51 | Q06609 | 2/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 4/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 2/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 2/20 | 0.37 |
| ▸ | RAB9A | P51151 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL728602 | 0.85 | P2RY6 (0.58) | P2RY6TAS2R38MIFCA1CA2 | |
| SCHEMBL3804765 | 0.83 | RAB9A (0.56) | P2RY6RAD51CA1CA2MAPT | |
| SCHEMBL13498468 | 0.81 | P2RY6 (0.64) | P2RY6MIFMAPTALDH1A1CYP3A4 | |
| SCHEMBL31651948 | 0.78 | P2RY6 (0.56) | P2RY6MIFCA1CA2MAPT | |
| SCHEMBL14511451 | 0.78 | TAS2R38 (0.75) | TAS2R38CA1CA2MAPTALDH1A1 | |
| SCHEMBL14341482 | 0.78 | P2RY6 (0.59) | P2RY6CA1CA2MAPTALDH1A1 | |
| SCHEMBL14605344 | 0.78 | P2RY6 (0.72) | P2RY6MAPTALDH1A1CYP3A4KMT2A | |
| SCHEMBL4572230 | 0.76 | P2RY6 (0.53) | P2RY6MIFRAD51CA1CA2 | |
| SCHEMBL6226041 | 0.75 | RAD51 (0.54) | P2RY6RAD51MAPTALDH1A1KMT2A | |
| SCHEMBL1533523 | 0.75 | RAD51 (0.54) | P2RY6RAD51MAPTALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210253950-A1 | ULTRABRIGHT LUMINESCENT LANTHANIDE NANOPARTICLES COMPRISING TERBIUM, WITH LONGER EXCITED-STATE LIFETIME | UNIVERSITE PARIS SACLAY (FR) | 2021-08-19 | — | — | US | disclosed |
| US-11033642-B2 | Multidentate bifunctional chelating agents for radionuclide complexation in diagnostics and therapy | UNIVERSITAT ZURICH (CH) | 2021-06-15 | — | — | US | disclosed |
| EP-3591024-B1 | ULTRABRIGHT LUMINESCENT LANTHANIDE NANOPARTICLES COMPRISING TERBIUM, WITH LONGER EXCITED-STATE LIFETIME | UNIV STRASBOURG (FR) | 2021-01-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11033642-B2 | Multidentate bifunctional chelating agents for radionuclide complexation in diagnostics and therapy | AOC1, XDH, FOLR1 | P2RY6 1794/4885TAS2R38 4110/4885MIF 3697/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.